Shock Syndromes II
Franchini M, Lippi G. Prothrombin complex concen-
trates: an update. Blood Transfus. 2010;8(3):149-154.
https://doi.org/10.2450/2010.0149-09
FrΓΆhlich M, Mutschler M, Caspers M, et al. Trauma-
induced coagulopathy upon emergency room arrival: still
a significant problem despite increased awareness and
management? Eur J Trauma Emerg Surg. 2019;45(1):115-
124. https://doi.org/10.1007/s00068-017-0884-5
Frontera JA, Lewin JJ 3rd, Rabinstein AA, et al.
Guideline for reversal of antithrombotics in intracranial
hemorrhage: a statement for healthcare profession-
als from the Neurocritical Care Society and Society of
46. https://doi.org/10.1007/s12028-015-0222-x
Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J.
Portal hypertensive bleeding in cirrhosis: risk strati-
fication, diagnosis, and management: 2016 practice
guidance by the American Association for the Study of
Liver Diseases. Hepatology. 2017;65(1):310-335. https://
doi.org/10.1002/hep.28906
Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of
treatment delay on the effectiveness and safety of antifi-
brinolytics in acute severe haemorrhage: a meta-analysis
of individual patient-level data from 40β138 bleeding
org/10.1016/s0140-6736(17)32455-8
Godier A, Samama CM, Susen S. Plasma/platelets/red
blood cell ratio in the management of the bleeding trau-
matized patient: does it matter? Curr Opin Anaesthesiol.
2012;25(2):242-247.
https://doi.org/10.1097/
aco.0b013e32834fcc3e
Goldstein JN, Refaai MA, Milling TJ Jr, et al. Four-
factor prothrombin complex concentrate versus plasma
for rapid vitamin K antagonist reversal in patients need-
ing urgent surgical or invasive interventions: a phase 3b,
2015;385(9982):2077-2087.
https://doi.org/10.1016/
s0140-6736(14)61685-8
Gonzalez E, Moore EE, Moore HB, et al. Goal-directed
hemostatic resuscitation of trauma-induced coagulopa-
thy: a pragmatic randomized clinical trial comparing a
viscoelastic assay to conventional coagulation assays.
sla.0000000000001608
Gruen RL, Brohi K, Schreiber M, et al. Haemorrhage
control
in
severely
injured
patients.
2012;380(9847):1099-1108.
https://doi.org/10.1016/
s0140-6736(12)61224-0
Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical
381. https://doi.org/10.1186/cc2851
Haider AH, Chang DC, Efron DT, Haut ER, Crandall M,
Cornwell EE 3rd. Race and insurance status as risk factors
for trauma mortality. Arch Surg. 2008;143(10):945-949.
https://doi.org/10.1001/archsurg.143.10.945
Harrois A, Hamada SR, Duranteau J. Fluid resuscitation
and vasopressors in severe trauma patients. Curr Opin
mcc.0000000000000159
Hauser CJ, Boffard K, Dutton R, et al. Results of the
CONTROL trial: efficacy and safety of recombinant
activated factor VII in the management of refractory
traumatic hemorrhage. J Trauma. 2010;69(3):489-500.
https://doi.org/10.1097/ta.0b013e3181edf36e
Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion
of plasma, platelets, and red blood cells in a 1:1:1
vs a 1:1:2 ratio and mortality in patients with severe
trauma: the PROPPR randomized clinical trial.
2015;313(5):471-482.
https://doi.org/10.1001/
jama.2015.12
Innerhofer P, Fries D, Mittermayr M, et al. Reversal of
trauma-induced coagulopathy using first-line coagula-
tion factor concentrates or fresh frozen plasma (RETIC):
a single-centre, parallel-group, open-label, randomised
org/10.1016/s2352-3026(17)30077-7
Kaatz S, Kouides PA, Garcia DA, et al. Guidance on the
emergent reversal of oral thrombin and factor Xa inhibi-
doi.org/10.1002/ajh.23202
Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage
on trauma outcome: an overview of epidemiology, clinical
presentations, and therapeutic considerations. J Trauma.
2006;60(6
suppl):S3-S11.
https://doi.org/10.1097/01.
ta.0000199961.02677.19
Kcentra (prothrombin complex concentrate, human)
[prescribing information]. CSL Behring; April 2013.
Lacroix J, HΓ©bert PC, Fergusson DA, et al. Age of
transfused blood in critically ill adults. N Engl J
Med. 2015;372(15):1410-1418. https://doi.org/10.1056/
nejmoa1500704